PREPARATION AND EVALUATION OF ATENOLOL-β-CYCLODEXTRIN ORALLY DISINTEGRATING TABLETS USING CO-PROCESS CROSPOVIDONE-SODIUM STARCH GLYCOLATE

  • Nani Parfati Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
  • Karina Citra Rani Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia http://orcid.org/0000-0003-2421-5754
  • Nathanael Charles Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
  • Valencia Geovany Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia

Abstract

Objective: The aim of this current research was to formulate and analyze the characteristics of atenolol-β-cyclodextrin which using co-process crospovidone-sodium starch glycolate as the disintegrants. Evaluation which has been conducted on orally disintegrating tablets consist of wetting time, water absorption ratio, in vitro dispersion time, and dissolution.

Methods: Inclusion complex of atenolol-β-cyclodextrin which were prepared using solvent evaporation method, then formulated using co-processed crospovidone-sodium starch glycolate 1:1 (formula 1) and 1:2 (formula 2) into orally disintegrating tablets by direct compression technique. Orally disintegrating tablets of atenolol-β-cyclodextrin using a physical mixture of crospovidone-sodium starch glycolate 1:1 (formula 3), 1:2 (formula 4) was also prepared as a control. The prepared formulations (F1-F4) were evaluated by several parameters such as wetting time, water absorption ratio, in vitro dispersion time, and dissolution.

Results: Orally disintegrating tablets of atenolol-β-cyclodextrin using co-processed crospovidone-sodium starch glycolate 1:1 (formula 1) showed shorter wetting time (53.53±2.26 seconds) and in vitro dispersion time (47.44±2.49 seconds) compare to the other formulas. Formula 1 also exhibited the highest dissolution efficiency compare to the formula which was used in the physical mixture. The results of this study also revealed that there was a high correlation between in vitro dispersion time and dissolution efficiency of atenolol-β-cyclodextrin orally disintegrating tablets.

Conclusion: Orally disintegrating tablets of atenolol-β-cyclodextrin showed enhanced dissolution efficiency due to the presence of inclusion complex and co-processed crospovidone-sodium starch glycolate. Formula 1 was found to be the best formula in this study. This formula effectively reduces in vitro dispersion time, hence the dissolution efficiency became higher.

Keywords: Atenolol, orally disintegrating tablets, Inclusion complex, Co-processed, crospovidone, sodium starch glycolate

Author Biographies

Nani Parfati, Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
Lecturer Departement of Pharmaceutics, Faculty of Pharmacy, University of Surabaya
Karina Citra Rani, Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
Lecturer Departement of Pharmaceutics, Faculty of Pharmacy, University of Surabaya
Nathanael Charles, Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
Undergraduate students, faculty of Pharmacy, University of Surabaya
Valencia Geovany, Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Kalirungkut, Surabaya-60293, East Java, Indonesia
Undergraduate students, faculty of Pharmacy, University of Surabaya

References

1. Chang RK, Xiaodi, Guo, Burnside BA, Couch RA. Fast–dissolving tablet. Pharm Technol 2000;24:52-8.
2. Sandeep DJ, Rahul NK, Chetan MJ, Bharat WT, Vijay RP. Formulation and evaluation of fast dissolving oral film of levocetirizine dihydrochloride. Int J Pharm Pharm Sci 2012;4:337-441.
3. Morris LS, Schulz RM. Patient compliance-an overview. J Clin Pharm Ther 1992;17:283-95.
4. Taj R, Khan S. A study of reasons for non-compliance to psychiatric treatment. J Ayub Med Coll Abbottabad 2005;17:26-8.
5. Hahm HA, Augsburger LL. Orally disintegrating tablets and related tablet formulations. In: Pharmaceutical Dosage Forms: Tablets. New York: Informa Healthcare; 2008. p. 293-312.
6. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry: orally disintegrating tablets. New Hampshire eve: Division of drug information food and drug administration; 2008.
7. Behnke K, Sogaard J, Martin S, Baumi J, Ravindran AV, Agren H. Mirtazapine orally disintegrating tablets versus sertraline: a prospective onset of action study. J Clin Psychopharmacol 2003;23:358-64.
8. Diaz JE, Montoya EG, Negre JM, Lozano PP, Minarro M, Tico JR. Predicting orally disintegrating tablets formulations of ibuprofen tablets: an application of the new sedem-odt expert system. Eur J Pharm Biopharm 2012;80:638-48.
9. Brown D. Orally disintegrating tablets: taste over speed. Drug Delivery Technol 2001;3:58-61.
10. Nagar P, Singh K, Chauhan I, Madhu V, Yasir M, Khan A, et al. Orally disintegrating tablets: formulation, preparation, techniques, and evaluation. J Appl Pharm Sci 2011;4:35-45.
11. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach. 7thed. New York: McGraw-Hill; 2008.
12. Ranch KM, Koli AR, Vyas BA, Parikh RK, Vyas RB, Maniyar NR, et al. Formulation, design, and optimization of orodispersible tablets of atenolol. Int J Pharm Tech Res 2009;1:1559-63.
13. Sweetman. Martindale the complete drug reference. 36th ed. London: Pharmaceutical Press; 2009.
14. Florey K. Analytical profiles of the drug substance. Vol. 13. Orlando: Academic Press; 1984.
15. Buha SM, Baxi GA, Shrivastav PS. Liquid chromatography study on atenolol-β-cyclodextrin inclusion complex. ISRN Anal Chem 2012;1:1-8.
16. Mittapalli RK, Qhattal HS, Lockman PR, Yamsani MR. Varying efficacy of super disintegrants in orally disintegrating tablets among different manufacturers. Pharmazie 2010;65:805-10.
17. Nagendrakumar D, Raju SA, Shirsand SB, Para MS. Design of fast dissolving granisetron HCl tablets using novel co-processed super disintegrants. Int J Pharm Sci Rev Res 2010;12:58-62.
18. Kumare MM, Marathe RP, Kawade RM, Ghante MH, Shendarkar RR. Design of fast dissolving tablet of atenolol using novel co-processed superdisintegrants. Asian J Pharm Clin Res 2013;6 Suppl 3:81-5.
19. United States Pharmacopeial Convention. United States Pharmacopeia 40 National Formulary 35. Rockville: United States Pharmacopeial Committee; 2017. p. 2886-8.
20. Chandrasekhar P, Shahid MS, Niranjan BM. Formulation and evaluation of oral dispersible tablets of antihypertensive drug atenolol. Int J Pharm 2013;3 Suppl 2:79–84.
21. Venkateswarlu K, Naik SB, Chandrasekhar KB. Formulation and in vitro evaluation of orlistat orodispersible tablets for enhancement of dissolution rate. Int J Pharm Pharm Sci 2016;8:236-41.
22. Aulton M, Summers M. In aulton’s pharmaceutics the design and manufacture of medicines. Philadelphia: Churchill Livingstone; 2013. p. 187-99.
23. Avulapati S, Roy AP, Shashidhar KR, Reddy TU. Formulation and evaluation of taste masked and fast disintegrating losartan potassium tablets. Int J Drug Dev Res 2011;3:45-51.
24. Kulkarni SV, Kumar R, Basavaraj, Rao S, Ramesh B, Kumar A. Effect of superdisintegrants on the formulation of taste masked fast disintegrating lisinopril tablets. Int J Curr Pharm Res 2011;3:11-4.
25. Reddy BV, Navaneetha K, Reddy VR, Reddy PP, Reddy PU, Lavanya T. Formulation and evaluation of fast dissolving tablets of losartan potassium. Indo Am J Pharm Res 2014;4:2573-84.
26. Vijaya V, Niroosha C, Ravi M. Comparative formulation, evaluation, and optimization of imidapril mouth dissolving tablets using different synthetic superdisintegrating agents. Int J Pharm Pharm Sci 2016;8:150-6.
27. Mahendrakumar P, Liew CV, Heng PW. Review of disintegrants and disintegration phenomena. J Pharm Sci 2016;105:2545-55.
28. Preethi GB, Banerjee S, Shivakumar HN, Kumar RM. Formulation of fast dissolving tablets of doxazosin mesylate drug by direct compression method. Int J Appl Pharm 2017;9:22-8.
Statistics
160 Views | 204 Downloads
How to Cite
Parfati, N., Rani, K. C., Charles, N., & Geovany, V. (2018). PREPARATION AND EVALUATION OF ATENOLOL-β-CYCLODEXTRIN ORALLY DISINTEGRATING TABLETS USING CO-PROCESS CROSPOVIDONE-SODIUM STARCH GLYCOLATE. International Journal of Applied Pharmaceutics, 10(5), 190-194. https://doi.org/10.22159/ijap.2018v10i5.27982
Section
Original Article(s)